Back to UBS Group AG UBS Group AG

CNTBCNTB
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in CONNECT BIOPHARMA HLDGS LTD

UBS Group AG holds 66,451 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), worth $158,153 as of 2026-Q2. The position was increased (+2013x shares).

Current Value

$158,153

Current Shares

66,451

Total Value Change

+$157,849

Total Shares Change

+66,250

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
66,451
+2013x
$158,1530.0%$2.38
25
2026-Q1
Decreased
33
-99.0%
$860.0%$2.48
0
2025-Q4
Increased
3,165
+1474.6%
$8,9250.0%$2.70
18
2025-Q3
New
201
-
$3040.0%$1.32
17

Other major holders of CNTB: BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used